Yum China Holdings Inc
Yum China Holdings Inc (0YU.DE) Financial Performance & Income Statement Overview
Explore the financials of Yum China Holdings Inc (0YU.DE), including yearly and quarterly data on income, cash flow, and balance sheets.
Yum China Holdings Inc (0YU.DE) Income Statement & Financial Overview
View the income breakdown for Yum China Holdings Inc 0YU.DE across both annual and quarterly reports.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $2.79B | $2.98B | $2.60B | $3.07B |
Cost of Revenue | $2.31B | $2.41B | $2.24B | $2.52B |
Gross Profit | $476.00M | $572.00M | $356.00M | $550.00M |
Gross Profit Ratio | $0.17 | $0.19 | $0.14 | $0.18 |
R&D Expenses | $0.00 | $0.00 | $6.00M | $0.00 |
SG&A Expenses | $131.00M | $138.00M | $156.00M | $139.00M |
Operating Expenses | $131.00M | $173.00M | $205.00M | $179.00M |
Total Costs & Expenses | $2.48B | $2.58B | $2.44B | $2.70B |
Interest Income | $25.00M | $26.00M | $29.00M | $31.00M |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $109.00M | $109.00M | $121.00M | $120.00M |
EBITDA | $420.00M | $514.00M | $289.00M | $499.00M |
EBITDA Ratio | $0.15 | $0.17 | $0.11 | $0.16 |
Operating Income | $304.00M | $399.00M | $151.00M | $371.00M |
Operating Income Ratio | $0.11 | $0.13 | $0.06 | $0.12 |
Other Income/Expenses (Net) | $7.00M | $33.00M | $22.00M | $65.00M |
Income Before Tax | $311.00M | $432.00M | $173.00M | $436.00M |
Income Before Tax Ratio | $0.11 | $0.14 | $0.07 | $0.14 |
Income Tax Expense | $80.00M | $119.00M | $47.00M | $119.00M |
Net Income | $215.00M | $292.00M | $115.00M | $297.00M |
Net Income Ratio | $0.08 | $0.10 | $0.04 | $0.10 |
EPS | $0.58 | $0.78 | $0.30 | $0.77 |
Diluted EPS | $0.57 | $0.77 | $0.30 | $0.77 |
Weighted Avg Shares Outstanding | $373.00M | $376.00M | $379.00M | $384.00M |
Weighted Avg Shares Outstanding (Diluted) | $373.00M | $378.00M | $382.00M | $385.00M |
Over the past four quarters, Yum China Holdings Inc demonstrated steady revenue growth, increasing from $3.07B in Q3 2024 to $2.79B in Q2 2025. Operating income reached $304.00M in Q2 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $420.00M, reflecting operational efficiency. Net income dropped to $215.00M, with EPS at $0.58. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan